The Board of Directors of Kemira Oyj has decided on the maximum number of shares, which may be granted under the Restricted Share Plan during the year 2026

Kemira’s Board approved an annual quota of up to 103,490 shares that may be granted under its Restricted Share Plan for 2026; the continuous RSP is intended as a complementary share-based incentive for recruitment and retention and to align employee interests with shareholders. Awards are conditional, paid partly in Kemira shares and partly in cash to cover taxes, typically require continued employment to vest and may be subject to additional earning criteria, with restriction periods set by the Board between 12 and 40 months. The company noted the RSP sits alongside its performance-based long-term incentive arrangements; Kemira reported 2024 revenue of EUR 2.9bn and about 4,700 employees.

Analysis

Kemira’s Board approved a maximum quota of 103,490 shares that may be granted under the Restricted Share Plan (RSP) for 2026; the quota refers to a gross number of shares before withholding of applicable payroll tax. The RSP is continuous with board-determined restriction periods of 12–40 months, rewards paid partly in shares and partly in cash to cover taxes, and as a rule rewards lapse if employment ends before payment. The company reiterated the RSP is complementary to its performance-based long-term incentives and may be deployed specifically for executive recruitment or retention, with the possibility of additional earning criteria beyond continued service.

The announcement reinforces alignment of employee incentives with shareholders but does not change reported fundamentals; Kemira reported EUR 2.9bn revenue and ~4,700 employees in 2024. The firm published comparable RSP disclosures on 16 December in prior years (2021 and 2024), indicating a recurring governance practice rather than a one-off program. The market-impact signals classify the news as neutral with a low market impact score (0.08), implying limited immediate trading relevance.

Because the release omits outstanding share count and grant schedules, the actual dilution and compensation expense cannot be quantified from this notice alone. Investors should therefore treat the quota as administratively important but likely immaterial to valuation unless subsequent filings show larger grants, accelerated recruitment-related awards, or binding performance thresholds that materially increase share settlement or cash outflows.

Key Decisions for Investors

• Treat the RSP approval as neutral for valuation and maintain existing positions absent disclosure of material grants or executive hires,
• Monitor subsequent disclosures for actual grant sizes, vesting schedules and any performance criteria because those drive dilution and compensation expense,
• Flag any use of the RSP for major executive recruitment or retention as a potential catalyst and consider modest hedging or re-evaluation of the position if grant activity accelerates